| Tuesday, December 31st 2024 |
Massive Upside In Big Money Pharma Favorite? |
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors. Get the full details here |
Burst Content You May Have Missed
|
Forget AI, The Next Massive Trend Is Starting In 3,2,1...
|
In the early days of e-commerce, few could have imagined just how quickly video-driven, real-time product demonstrations would reshape global retail. But here we are: In China alone, live streaming e-commerce revenue soared from a roughly $64 billion market in 2019 to more than $300 billion by 2021, according to data compiled by Deloitte. Get the full details here |
How To Trade When Markets Hit All-time Highs |
With the market near all-time highs, buying stocks can look like a worrisome proposition and it's no surprise that many investors feel more comfortable sitting on the sidelines. Staying out of the market entirely, though, presents an opportunity cost in the form of lost potential returns. So, just what can investors worried about the market's performance and potential volatility do to limit their risks while still putting their money to work for them? Get the full details here |
1 Cloud SaaS Healthcare Stock to Buy on the Dip? |
It might surprise many that Veeva Systems Inc. (NYSE:VEEV), best known for its cloud-based software solutions tailored to the life sciences industry, has maintained a core principle of putting customer success and product excellence ahead of short-term gains. Get the full details here |
|
 |
|
| | Advertising Disclosure: This email may contain paid advertisements. Summa Money publishes 4 newsletters with various areas of focus. The Ivy is delivered 3x per week with a focus on investments that could generate passive income. The Burst is delivered 2x per week with a focus on growth stocks. The Spotlight is delivered 1x per week with a focus on high potential stocks and economic insights. The Daily is an occasional newsletter with a focus on the best investing stories and news from around the world. We hope you enjoy them all, but feel free to unsubscribe from the content you do not want to receive. If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking the unsubscribe link at the bottom of this email. If you have any questions, please send an email with your questions to support@summamoney.com. Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here. If you can't see this message, view it in your browser. You are receiving this e-mail at diansastroxz.forex@blogger.com as a part of your free subscription to the Burst Newsletter. To read our privacy policy follow this link. or To unsubscribe by mail, write us at: Summa Money | 2319 N Andrews Ave. Fort Lauderdale, FL 33311 Website: Summa Money Nothing in this email should be considered personalized financial advice. Staff members at Summa Money are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Copyright 2024 Summa Money. All rights reserved. Advertise With Us |
|
|
In order to unsubscribe from this mailing list, please click
here 
Post a Comment
Post a Comment